Old Second Bancorp Q2 EPS $0.30 Misses $0.32 Estimate

Old Second Bancorp (NASDAQ:OSBC) reported quarterly earnings of $0.30 per share which missed the analyst consensus estimate of $0.32 by 6.25 percent. This is a 3.23 percent decrease over earnings of $0.31 per share from

byBill Haddad

July 21, 2021

1 minute read

Mid-Day Market Update: Crude Oil Edges Higher As EIA Reports Drop In Crude Oil Inventories

By Lisa Levin

Today, 8:57 PM

US stocks remained higher on Wednesday, with the Dow Jones surging more than 250 points.

DCFC

Earnings

Earnings Preview: Ollie’s Bargain Outlet

By Benzinga Insights

Today, 8:57 PM

Ollie's Bargain Outlet (NASDAQ:OLLI) is set to give its latest quarterly earnings report on Wednesday, 2022-03-23. Here's what investors need to know before the announcement. Analysts estimate that Ollie's Bargain Outlet will report an earnings per share (EPS) of $0.66.

OLLI

News

Arbutus Biopharma Issued Update on AB-729 and AB-836, an siRNA and Capsid Inhibitor Currently in Development for the Treatment of Chronic Hepatitis B Infection

By Charles Gross

Today, 8:57 PM

https://docs.publicnow.com/viewDoc?hash_primary=FDC8FA6E482AC847C1071B9C6541ED81325D0867

ABUS

Here’s How Much You Would Have Made Owning Photronics Stock In The Last 5 Years

By Benzinga Insights

Today, 8:57 PM

Photronics (NASDAQ:PLAB) has outperformed the market over the past 5 years by 6.43% on an annualized basis producing an average annual return of 16.57%. Currently, Photronics has a market capitalization of $1.03 billion.

PLAB

Old Second Bancorp Q2 EPS $0.30 Misses $0.32 Estimate

Related Posts

Mid-Day Market Update: Crude Oil Edges Higher As EIA Reports Drop In Crude Oil Inventories

Earnings Preview: Ollie’s Bargain Outlet

Arbutus Biopharma Issued Update on AB-729 and AB-836, an siRNA and Capsid Inhibitor Currently in Development for the Treatment of Chronic Hepatitis B Infection

Here’s How Much You Would Have Made Owning Photronics Stock In The Last 5 Years